Literature DB >> 35357327

Authors' Reply to: Challenges in Measuring What Matters to Patients With Diabetes. Comment on "Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review".

Yu Heng Kwan1,2,3, Jie Kie Phang4, Sungwon Yoon1,4, Lian Leng Low1,4,5,6,7,8.   

Abstract

Entities:  

Keywords:  PROMs; diabetes; level of evidence; measurement properties; methodological quality; patient reported outcome; patient-reported outcome measures; systematic review

Mesh:

Year:  2022        PMID: 35357327      PMCID: PMC9015756          DOI: 10.2196/37957

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   7.076


× No keyword cloud information.
We would like to respond to the letter written by Rutters et al [1] with regard to our paper, “Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review” [2]. We noted the concerns from Rutters et al [1], but we would like to offer some explanations. First, the selection criteria of our systematic review were restricted to patient-reported outcome measures (PROMs) that are tested in patients with type 2 diabetes mellitus (T2DM) only. The study on the development and validation of the National Diabetes Register Survey included patients with other forms of diabetes (ie, type 1 diabetes) [3], and, therefore, was excluded from our analysis. We focused on T2DM since existing evidence has demonstrated that patients’ behaviors influencing disease management differ by different diabetes subtypes [4,5]. Therefore, the PROMs used to guide interventions and patient care may be different and should be reviewed separately. Another consideration was related to our concerns that combining all validation studies of PROMs in different forms of diabetes would reduce the readability of the paper due to the large number of studies available. Second, due to the large number of PROMs included in the review, we decided to analyze the measurement properties of the PROMs on a per-PROM basis instead to maintain the readability of the paper. We also agree with Rutters et al [1] that many health-related quality of life (HRQOL) PROM subscales do not measure HRQOL but actually measure overall quality of life, and that characteristics of the individual or environment should be considered patient-reported experience measures. This is further complicated by the issue of problematic definitions of HRQOL in the literature [6]; thus, further study detailing the different constructs measured by subscales of PROMs is warranted. We are grateful that the authors have taken the effort to provide constructive comments on our paper. The issues brought up by Rutters et al [1] echoed the need to have consensus between clinicians and psychometrists to measure what is relevant to patients. The content of the existing PROMs is indeed heterogeneous, and there are too many PROMs that have questionable validity. We agree that more awareness is needed, including developing and implementing core outcome sets for patients with diabetes. In conclusion, there is a need for a systematic review to summarize all available PROMs for patients with diabetes with emphasis on the constructs being measured, as well as a comprehensive evidence synthesis of the measurement properties of all subscales of PROMs (which was not the focus of our systematic review). Clinicians and researchers should work with patients with diabetes to develop a core outcome measurement set for use in diabetes care and research.
  6 in total

1.  A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability.

Authors:  Maria Svedbo Engström; Janeth Leksell; Unn-Britt Johansson; Katarina Eeg-Olofsson; Sixten Borg; Bo Palaszewski; Soffia Gudbjörnsdottir
Journal:  Patient Educ Couns       Date:  2017-07-14

2.  Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?

Authors:  Milad Karimi; John Brazier
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

3.  The locus of control in patients with Type 1 and Type 2 diabetes managed by individual and group care.

Authors:  M Trento; M Tomelini; M Basile; E Borgo; P Passera; V Miselli; M Tomalino; F Cavallo; M Porta
Journal:  Diabet Med       Date:  2008-01       Impact factor: 4.359

4.  Challenges in Measuring What Matters to Patients With Diabetes. Comment on "Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review".

Authors:  Femke Rutters; Ellen Elsman; Lenka Groeneveld; Marlous Langendoen-Gort; Lidwine Mokkink; Caroline Terwee
Journal:  J Med Internet Res       Date:  2022-03-31       Impact factor: 7.076

5.  Knowledge, Perceptions and Concerns of Diabetes -Associated Complications Among Individuals Living with Type 1 and Type 2 Diabetes Mellitus.

Authors:  Clara Sanz-Nogués; Mohamad Mustafa; Helen Burke; Timothy O'Brien; Cynthia M Coleman
Journal:  Healthcare (Basel)       Date:  2020-01-30

6.  Measurement Properties of Patient-Reported Outcome Measures for Diabetes: Systematic Review.

Authors:  Priscilla Jia Ling Wee; Yu Heng Kwan; Dionne Hui Fang Loh; Jie Kie Phang; Troy H Puar; Truls Østbye; Julian Thumboo; Sungwon Yoon; Lian Leng Low
Journal:  J Med Internet Res       Date:  2021-08-13       Impact factor: 5.428

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.